Covered recipient · General Payments record
CANDICE B ABUSO
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$5,274.15
- Reported across 380 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $407.91 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $145.11 | 10 |
| Lilly USA, LLC | $140.94 | 10 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $32.19 | 2 |
| PFIZER INC. | $31.93 | 2 |
| IRONWOOD PHARMACEUTICALS, INC | $22.16 | 1 |
| Abbott Laboratories | $22.03 | 1 |
| Acerta Pharma LLC | $13.55 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20182019202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $22.03 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125269734 | CMS |
| ABBVIE INC. | $25.20 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103170814 | CMS |
| ABBVIE INC. | $6.52 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103170816 | CMS |
| ABBVIE INC. | $30.35 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103170818 | CMS |
| ABBVIE INC. | $33.85 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103170820 | CMS |
| ABBVIE INC. | $17.04 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103170822 | CMS |
| ABBVIE INC. | $6.19 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103170824 | CMS |
| ABBVIE INC. | $5.92 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103170826 | CMS |
| ABBVIE INC. | $6.21 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103170828 | CMS |
| ABBVIE INC. | $7.07 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103170830 | CMS |
| ABBVIE INC. | $6.76 | 11/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103170832 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.55 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105743482 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $16.37 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118152327 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $15.82 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118152325 | CMS |
| IRONWOOD PHARMACEUTICALS, INC | $22.16 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153752270 | CMS |
| Lilly USA, LLC | $20.95 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136083034 | CMS |
| Lilly USA, LLC | $18.14 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136080592 | CMS |
| Lilly USA, LLC | $19.89 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136083036 | CMS |
| Lilly USA, LLC | $6.47 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136083038 | CMS |
| Lilly USA, LLC | $19.82 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136084082 | CMS |
| Lilly USA, LLC | $6.58 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136083570 | CMS |
| Lilly USA, LLC | $6.85 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136087578 | CMS |
| Lilly USA, LLC | $17.62 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136083572 | CMS |
| Lilly USA, LLC | $6.60 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136032994 | CMS |
| Lilly USA, LLC | $18.02 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136084084 | CMS |
| PFIZER INC. | $17.15 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131278097 | CMS |
| PFIZER INC. | $14.78 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131548401 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.